SamerNakhleMD

Endocrinology • Las Vegas, NV

Diabetes, Lipid Metabolism

Endocrinologist at Palm medical group

Join to view full profile

Dr. Nakhle is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Nakhle's full profile

Already have an account?

Office
9280 W Sunset Rd
Suite 306
Las Vegas, NV 89148
Phone+1 702-696-7256
Is this information wrong?

Education & Training

University of Nebraska Medical Center College of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 1998 - 2000
St Barnabas HospitalResidency, Internal Medicine, 1995 - 1998
Damascus University Faculty of MedicineClass of 1991

Certifications & Licensure

NV State Medical License 2001 - 2025
IA State Medical License 2000 - 2002
IN State Medical License 2000 - 2001

Awards, Honors, & Recognition

Fellow (FACE) American Association of Clinical Endocrinology

Clinical Trials

An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Approved for marketing
A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM) Start of enrollment: 2014 Feb 01
Terminated
Phase 4
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2014 Apr 01
Terminated
Phase 2
A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol Start of enrollment: 2014 Oct 01
Terminated
Phase 3
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Start of enrollment: 2015 Sep 01
Completed
Phase 2
An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2015 Oct 20
Completed
Phase 3
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2017 May 24
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 di...
Elena A Christofides, Orlando Puente, Paul Norwood, Douglas Denham, Hiralal Maheshwari, Michael Lillestol, Terence Hart, Samer Nakhle, Anurekha Chadha, David Fitz-Patr...> ;Diabetes, Obesity & Metabolism. 2024 Apr 1
Safety and Efficacy of Switching SAR341402 Insulin Aspart and Originator Insulin Aspart vs Continuous Use of Originator Insulin Aspart in Adults With Type 1 Diabetes: ...
Shah, V., Barnes, C., Wernicke-Panten, K., Kramer, D., Schmider, W., Pierre, S., Teichert, L., Rotthaeuser, B., Mukherjee, B., Bailey, T., Al-Karadsheh, A., Mandry, J....> ;Journal of Diabetes Science and Technology. 2024 Feb 29
Pharmacokinetic similarity of switching SAR341402 insulin aspart biosimilar and NovoLog insulin aspart versus continuous use of NovoLog in adults with type 1 diabetes:...
Viral N Shah, Amer Al-Karadsheh, Cathy Barnes, Jose Mandry, Samer Nakhle, Karin Wernicke-Panten, Daniel Kramer, Wolfgang Schmider, Suzanne Pierre, Lenore Teichert, Bae...> ;Diabetes, Obesity & Metabolism. 2024 Feb 1
12 citations
Tildacerfont in Adults With Classic Congenital Adrenal Hyperplasia: Results from Two Phase 2 Studies.
Kyriakie Sarafoglou, Chris Barnes, Michael Huang, Erik A. Imel, Ivy-Joan Madu, Deborah P. Merke, David Moriarty, Samer Nakhle, Ron S. Newfield, Maria G. Vogiatzi, Rich...> ;The Journal of Clinical Endocrinology and Metabolism. 2021 Oct 21
24 citations
Exenatide once weekly improved 24‐hour glucose control and reduced glycaemic variability in metformin‐treated participants with type 2 diabetes: a randomized, placebo‐...
Juan P. Frías, Samer Nakhle, James Ruggles, Sergey B. Zhuplatov, Eric J. Klein, Rong Zhou, Poul Strange> ;Diabetes, Obesity & Metabolism. 2017 Jan 1
7 citations
Patients with Acromegaly Presenting with Colon Cancer: A Case Series.
Murray B. Gordon, Samer Nakhle, William H. Ludlam> ;Case Reports in Endocrinology. 2016 Nov 29
12 citations
Acute effects of insulin on aqueous humor flow in patients with type 1 diabetes
James T. Lane, Carol B. Toris, Samer N. Nakhle, David M. Chacko, Yun Liang Wang, Michael E. Yablonski> ;American Journal of Ophthalmology. 2001 Sep 1
Elevated prevalence of hepatitis C infection in users of United States veterans medical centers.
Dominitz, J. A., Boyko, E. J., Koepsell, T. D., Heagerty, P. J., Maynard, C., Sporleder, J. L., Stenhouse, A., Kling, M. A., Hrushesky, W., Zeilman, C., Sontag, S., Sh...> ;Hepatology. 2005 Jan
Join now to see all

Lectures

PTH/PTHrP and CaSR Signaling
ENDO 2019 - New Orleans, LA - 3/26/2019

Press Mentions

Health Care Quarterly’s 2020 Top DoctorsAugust 20th, 2020

Professional Memberships

Endocrine Society - ENDO
Member

Other Languages

Arabic

Hospital Affiliations

Southern Hills Hospital and Medical CenterLas Vegas, Nevada
Spring Valley Hospital Medical CenterLas Vegas, Nevada
St. Rose Dominican Hospitals - San Martin CampusLas Vegas, Nevada
MountainView HospitalLas Vegas, Nevada
North Las Vegas VA Medical CenterNorth Las Vegas, Nevada

SamerNakhleMD

Dr. Nakhle is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Press Mentions

Professional Memberships

Other Languages

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.